Ronald Todd Plott, Director at Phio Pharmaceuticals, bought PHIO on Sep 29, 2026
Data as of Oct 16
- Traded
- Sep 29, 2026
- Disclosed
- Sep 30, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PHIO since disclosure
−15.4%
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Sep 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYRonald Todd Plott DirectorPHIO Phio Pharmaceuticals Corp.$5.2Kdisclosed Sep 30 · filed 2 days after the trade